ArticleLeukemia2014

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.

V Bachanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.